Annual Current Ratio
4.17
-2.29-35.45%
31 December 2023
Summary:
Aileron Therapeutics annual current ratio is currently 4.17, with the most recent change of -2.29 (-35.45%) on 31 December 2023. During the last 3 years, it has risen by +0.05 (+1.21%). ALRN annual current ratio is now -60.99% below its all-time high of 10.69, reached on 31 December 2021.ALRN Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
3.30
-1.39-29.64%
30 September 2024
Summary:
Aileron Therapeutics quarterly current ratio is currently 3.30, with the most recent change of -1.39 (-29.64%) on 30 September 2024. Over the past year, it has dropped by -4.58 (-58.12%). ALRN quarterly current ratio is now -84.23% below its all-time high of 20.93, reached on 31 March 2021.ALRN Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALRN Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.5% | -58.1% |
| 3 y3 years | +1.2% | -72.3% |
| 5 y5 years | +3.0% | -19.9% |
ALRN Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -61.0% | +1.2% | -72.3% | +17.0% |
| 5 y | 5 years | -61.0% | +24.5% | -84.2% | +48.0% |
| alltime | all time | -61.0% | +163.9% | -84.2% | +50.7% |
Aileron Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 3.30(-29.6%) |
| June 2024 | - | 4.69(+66.3%) |
| Mar 2024 | - | 2.82(-32.4%) |
| Dec 2023 | 4.17(-35.4%) | 4.17(-47.1%) |
| Sept 2023 | - | 7.88(-32.4%) |
| June 2023 | - | 11.66(+96.6%) |
| Mar 2023 | - | 5.93(-8.2%) |
| Dec 2022 | 6.46(-39.6%) | 6.46(+8.4%) |
| Sept 2022 | - | 5.96(-8.4%) |
| June 2022 | - | 6.51(-32.5%) |
| Mar 2022 | - | 9.65(-9.7%) |
| Dec 2021 | 10.69(+159.5%) | 10.69(-10.4%) |
| Sept 2021 | - | 11.93(-15.3%) |
| June 2021 | - | 14.08(-32.7%) |
| Mar 2021 | - | 20.93(+408.0%) |
| Dec 2020 | 4.12 | 4.12(+35.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | 3.04(-23.8%) |
| June 2020 | - | 3.99(+78.9%) |
| Mar 2020 | - | 2.23(-33.4%) |
| Dec 2019 | 3.35(-17.3%) | 3.35(-18.7%) |
| Sept 2019 | - | 4.12(-31.8%) |
| June 2019 | - | 6.04(+94.2%) |
| Mar 2019 | - | 3.11(-23.2%) |
| Dec 2018 | 4.05(-61.8%) | 4.05(-4.3%) |
| Sept 2018 | - | 4.23(-27.7%) |
| June 2018 | - | 5.85(-36.1%) |
| Mar 2018 | - | 9.15(-13.7%) |
| Dec 2017 | 10.60(+104.6%) | 10.60(-8.4%) |
| Sept 2017 | - | 11.57(+428.3%) |
| June 2017 | - | 2.19(-60.7%) |
| Mar 2017 | - | 5.57(+7.5%) |
| Dec 2016 | 5.18(+227.8%) | 5.18 |
| Dec 2015 | 1.58 | - |
FAQ
- What is Aileron Therapeutics annual current ratio?
- What is the all time high annual current ratio for Aileron Therapeutics?
- What is Aileron Therapeutics annual current ratio year-on-year change?
- What is Aileron Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly current ratio year-on-year change?
What is Aileron Therapeutics annual current ratio?
The current annual current ratio of ALRN is 4.17
What is the all time high annual current ratio for Aileron Therapeutics?
Aileron Therapeutics all-time high annual current ratio is 10.69
What is Aileron Therapeutics annual current ratio year-on-year change?
Over the past year, ALRN annual current ratio has changed by -2.29 (-35.45%)
What is Aileron Therapeutics quarterly current ratio?
The current quarterly current ratio of ALRN is 3.30
What is the all time high quarterly current ratio for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly current ratio is 20.93
What is Aileron Therapeutics quarterly current ratio year-on-year change?
Over the past year, ALRN quarterly current ratio has changed by -4.58 (-58.12%)